Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


The ‘Sanming Model’: Bad Omen Or Hope For Pharma In China?

Executive Summary

Pharma executives in China may soon get an earful of the name Sanming, as the populist healthcare reform model that began at the small city in Fujian is rolled out nationwide and impacts profoundly how drugs are tendered, priced and distributed.

You may also be interested in...

Emerging China Compliance Issues Warrant Closer Watch: Experts

A new dual receipting system, a potential registry for sales reps, and rules over false advertisements and promotion are just some of the many and growing challenges pressuring pharna corporate compliance officers in China, experts attending a recent conference said.

China Imposes Tough New Curbs On Rep Sales Activities

Tough new rules from China’s State Council have put the country’s one million medical reps into limbo as their employers scrabble to get to grips with broad curbs on sales activities.

Reign In Your Distributors And Reps, Chinese Regulator Cautions

Manufacturers beware, the rollout of a new receipts system could impact how drugs are distributed and sold to public hospitals in China over the course of the new year.

Related Content


Latest News
See All



Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts